The results from quantitative MS analysis were validated by immunoblotting, focusing on the proteins VASP and PAR4, which are detectable in both samples, but expressed at higher levels in PEVs-THR and PEVs-BCC, respectively (Fig. 4B). The gene discussed is VASP; the disease is skin basal cell carcinoma.